Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Response to Abatacept in RA
NCT01299961Phase 3Completed
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2011
- Primary completion
- Feb 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by University of California, Los Angeles. Started Mar 2011; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01299961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299961.